Acute renal failure in bone marrow transplant patients admitted to the intensive care unit. 2002

Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
Department of Nephrology, Maisonneuve-Rosemont Hospital and Guy-Bernier Research Center, University of Montreal, Que, Canada.

OBJECTIVE Review of bone marrow transplant (BMT) cases admitted to our intensive care unit (ICU) and to compare co-morbidity and outcome of BMT patients developing or not developing acute renal failure (ARF). METHODS A case review of BMT patients admitted to the ICU (a 16-bed medico-surgical ICU in a tertiary care teaching institution) over a 4-year period. RESULTS Between January 1994 and December 1998, 57 among 441 BMT patients (12.9%) were admitted to the ICU, mainly for respiratory distress (58%) and hypotension (32%). Forty-two patients (73.7%) presented ARF as defined as a doubling of serum creatinine. Compared to the 15 other patients, ARF patients had a higher APACHE II score (30 +/- 8 vs. 25 +/- 7, p < 0.05). For ARF vs. non-ARF patients, there was no difference in age (43.8 +/- 10.8 vs. 44.3 +/- 11.1 years), in requirement for mechanical ventilation (76 vs. 73%) and vasopressors (69 vs. 60%), and in prevalence of graft-versus-host disease (19 vs. 13%) or neutropenia (69 vs. 67%), but the prevalence of sepsis (83 vs. 60%) and liver failure (69 vs. 40%) was higher. Maximum serum bilirubin was markedly increased in ARF compared to non-ARF patients (p < 0.005). For both subgroups, no difference in the administration of potential nephrotoxic agents was identified. Usually, ARF was considered multifactorial by clinicians, with ATN being the most frequent diagnosis (55%). Maximum serum creatinine reached a mean of 330 +/- 130 micromol/l. In 74% of cases, ARF occurred concomitantly or after admission to the ICU. Oligoanuria was present in 38%, whereas polyuria was observed in 17%. Fourteen ARF patients (33%) required dialytic support. Mortality rates were significantly different in ARF vs. non-ARF patients (88 vs. 60%, p < 0.05). Predictive factors for the development of ARF were liver failure (odds ratio (OR) 5.9), low serum albumin (OR 1.2) and APACHE II score (OR 1.1), whereas variables predictive of mortality were mechanical ventilation (OR 14.8), ARF (OR 5.8), liver failure (OR 3.7), and APACHE II score (OR 1.2). CONCLUSIONS This study confirms that ARF in BMT patients admitted to the ICU is frequent, multifactorial, related to liver failure, and that its development has a negative impact on outcome.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015897 Comorbidity The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
January 2017, Jornal brasileiro de nefrologia,
Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
September 1998, American journal of respiratory and critical care medicine,
Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
July 2009, European journal of gastroenterology & hepatology,
Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
November 2015, Transplantation proceedings,
Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
December 2014, Annals of transplantation,
Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
March 2009, Journal of the Indian Medical Association,
Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
January 2021, Annals of hepatology,
Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
January 2021, Annals of hepatology,
Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
January 2021, Annals of hepatology,
Isabelle Létourneau, and Marc Dorval, and Robert Bélanger, and Martin Légaré, and Louise Fortier, and Martine Leblanc
June 2006, Seminars in respiratory and critical care medicine,
Copied contents to your clipboard!